Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung

p53 Mutations in Human Cancers

1991 • 8,133 citations

p53, the Cellular Gatekeeper for Growth and Division

1997 • 7,621 citations

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

Cancer—Principles & Practice of Oncology

1983 • 1,403 citations

Clinical Implications of the p53 Tumor-Suppressor Gene

1993 • 1,341 citations

The new World Health Organization classification of lung tumours

2001 • 1,131 citations

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

1994 • 981 citations

The biology of erbB-2/nue/HER-2 and its role in cancer

1994 • 975 citations

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1992 • 855 citations

Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990

1997 • 535 citations

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.

2001 • 455 citations

p185neu expression in human lung adenocarcinomas predicts shortened survival.

1990 • 440 citations

The role of vascular endothelial growth factor in pathological angiogenesis

1995 • 419 citations

Survival in early-stage non-small cell lung cancer

1995 • 372 citations

Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

1997 • 313 citations

United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females

1996 • 264 citations

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

2000 • 261 citations

Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.

1990 • 232 citations

c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties

1995 • 210 citations

Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis

2001 • 208 citations

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1991 • 185 citations

Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components

2003 • 180 citations

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

1998 • 180 citations

Non-Small Cell Lung Cancer

2003 • 176 citations

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1997 • 169 citations

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

1995 • 160 citations

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

1996 • 156 citations

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.

1994 • 139 citations

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.

1996 • 133 citations

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

2003 • 112 citations

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

1999 • 107 citations

Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?

1998 • 106 citations

Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines

1996 • 104 citations

Immunohistochemical study of p53 in human lung carcinomas.

1993 • 103 citations

The prognostic significance of p53 andbcl-2 expression in lung adenocarcinoma and its correlation with ki-67 growth fraction

1997 • 100 citations

Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations

1993 • 96 citations

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non–small-cell lung cancer

2002 • 94 citations

Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer

1995 • 81 citations

Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.

1996 • 64 citations

HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.

2000 • 55 citations

Tumor angiogenesis and recurrence in stage I non-small cell lung cancer

1999 • 52 citations

Untitled

2002 • 47 citations

Immunohistochemical Study of Thyroid Transcription Factor-1 and HER2/ neu in Non–Small Cell Lung Cancer: Strong Thyroid Transcription Factor-1 Expression Predicts Better Survival

2002 • 41 citations

Nuclear p53 accumulation by small‐sized adenocarcinomas of the lung

1996 • 32 citations

Towards a biological staging model for operable non-small cell lung cancer

2001 • 31 citations

Nuclear Accumulation of p53 Is a Potential Marker for the Development of Squamous Cell Lung Cancer in Smokers

2003 • 22 citations

Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.

2003 • 13 citations